AKT1 and neoplasm: This was particularly true in tumours having shown the highest response under treatment (with the triple combination), AKT is one of the main mTOR-related messengers (Smolewski, 2006) and the current development of mTOR inhibitors as anticancer drugs is very promising (Faivre et al, 2006b).